These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
497 related items for PubMed ID: 22303863
1. Effect of intraarterial papaverine or nimodipine on vessel diameter in patients with cerebral vasospasm after subarachnoid hemorrhage. Kerz T, Boor S, Beyer C, Welschehold S, Schuessler A, Oertel J. Br J Neurosurg; 2012 Aug; 26(4):517-24. PubMed ID: 22303863 [Abstract] [Full Text] [Related]
2. Continuous local intra-arterial nimodipine administration in severe symptomatic vasospasm after subarachnoid hemorrhage. Musahl C, Henkes H, Vajda Z, Coburger J, Hopf N. Neurosurgery; 2011 Jun; 68(6):1541-7; discussion 1547. PubMed ID: 21311378 [Abstract] [Full Text] [Related]
3. Intra-arterial papaverine infusions for the treatment of cerebral vasospasm induced by aneurysmal subarachnoid hemorrhage. Liu JK, Couldwell WT. Neurocrit Care; 2005 Jun; 2(2):124-32. PubMed ID: 16159054 [Abstract] [Full Text] [Related]
4. Intraarterial infusion of papaverine and change of cerebral hemodynamics in symptomatic cerebral vasospasm. Minami H, Kuwamura K, Tamaki N. Kobe J Med Sci; 2001 Aug; 47(4):169-79. PubMed ID: 11733656 [Abstract] [Full Text] [Related]
5. Effect of Intra-Arterial and Intravenous Nimodipine Therapy of Cerebral Vasospasm After Subarachnoid Hemorrhage on Cerebrovascular Reactivity and Oxygenation. Hockel K, Diedler J, Steiner J, Birkenhauer U, Ernemann U, Schuhmann MU. World Neurosurg; 2017 May; 101():372-378. PubMed ID: 28232152 [Abstract] [Full Text] [Related]
6. Endovascular therapy for vasospasm after aneurysmatic subarachnoid hemorrhage. Kerz T, Boor S, Ulrich A, Beyer C, Hechtner M, Mueller-Forell W. Br J Neurosurg; 2016 Oct; 30(5):549-53. PubMed ID: 27080311 [Abstract] [Full Text] [Related]
7. Efficacy of multiple intraarterial papaverine infusions for improvement in cerebral circulation time in patients with recurrent cerebral vasospasm. Liu JK, Tenner MS, Gottfried ON, Stevens EA, Rosenow JM, Madan N, MacDonald JD, Kestle JR, Couldwell WT. J Neurosurg; 2004 Mar; 100(3):414-21. PubMed ID: 15035276 [Abstract] [Full Text] [Related]
8. Reversal of radiographically impending stroke with multiple intraarterial papaverine infusions in severe diffuse cerebral vasospasm induced by subarachnoid hemorrhage. Liu JK, Tenner MS, Oestreich HM, Couldwell WT. Acta Neurochir (Wien); 2001 Dec; 143(12):1249-55; discussion 1256. PubMed ID: 11810389 [Abstract] [Full Text] [Related]
9. Resistant vasospasm in subarachnoid hemorrhage treated with continuous intraarterial nimodipine infusion. Doukas A, Petridis AK, Barth H, Jansen O, Maslehaty H, Mehdorn HM. Acta Neurochir Suppl; 2011 Dec; 112():93-6. PubMed ID: 21691994 [Abstract] [Full Text] [Related]
10. Continuous selective intra-arterial application of nimodipine in refractory cerebral vasospasm due to aneurysmal subarachnoid hemorrhage. Ott S, Jedlicka S, Wolf S, Peter M, Pudenz C, Merker P, Schürer L, Lumenta CB. Biomed Res Int; 2014 Dec; 2014():970741. PubMed ID: 24527461 [Abstract] [Full Text] [Related]
11. Intraarterial nimodipine for the treatment of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage: a preliminary study. Dehdashti AR, Binaghi S, Uske A, Regli L. Neurol India; 2011 Dec; 59(6):810-6. PubMed ID: 22234190 [Abstract] [Full Text] [Related]
12. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study. Ehlert A, Schmidt C, Wölfer J, Manthei G, Jacobs AH, Brüning R, Heindel W, Ringelstein EB, Stummer W, Pluta RM, Hesselmann V. J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034 [Abstract] [Full Text] [Related]
13. Efficacy of intra-arterial nimodipine in the treatment of cerebral vasospasm complicating subarachnoid haemorrhage. Hui C, Lau KP. Clin Radiol; 2005 Sep; 60(9):1030-6. PubMed ID: 16124986 [Abstract] [Full Text] [Related]
14. Nimodipine attenuation of early brain dysfunctions is partially related to its inverting acute vasospasm in a cisterna magna subarachnoid hemorrhage (SAH) model in rats. Zhao WJ, Wu C. Int J Neurosci; 2012 Oct; 122(10):611-7. PubMed ID: 22694164 [Abstract] [Full Text] [Related]
15. Higher dose intra-arterial milrinone and intra-arterial combined milrinone-nimodipine infusion as a rescue therapy for refractory cerebral vasospasm. Duman E, Karakoç F, Pinar HU, Dogan R, Fırat A, Yıldırım E. Interv Neuroradiol; 2017 Dec; 23(6):636-643. PubMed ID: 28956512 [Abstract] [Full Text] [Related]
16. Intra-arterial nimodipine for severe cerebral vasospasm after aneurysmal subarachnoid hemorrhage: influence on clinical course and cerebral perfusion. Hänggi D, Turowski B, Beseoglu K, Yong M, Steiger HJ. AJNR Am J Neuroradiol; 2008 Jun; 29(6):1053-60. PubMed ID: 18372422 [Abstract] [Full Text] [Related]
17. Intra-arterial nimodipine to treat symptomatic cerebral vasospasm following traumatic subarachnoid haemorrhage. Technical case report. Conti A, Angileri FF, Longo M, Pitrone A, Granata F, La Rosa G. Acta Neurochir (Wien); 2008 Nov; 150(11):1197-202; discussion 1202. PubMed ID: 18958388 [Abstract] [Full Text] [Related]
18. Effects of dose-response of topical administration of nimodipine on cerebral vasospasm after subarachnoid hemorrhage in rabbits. Yin YH, Wang F, Pan YH, Wang Y, Wang Y, Luo QZ, Jiang JY. Am J Med Sci; 2009 Feb; 337(2):123-5. PubMed ID: 19214028 [Abstract] [Full Text] [Related]
19. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study. Schmid-Elsaesser R, Kunz M, Zausinger S, Prueckner S, Briegel J, Steiger HJ. Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884 [Abstract] [Full Text] [Related]
20. Real-Time, In Vivo Monitoring, and Quantitative Assessment of Intra-Arterial Vasospasm Therapy. Gölitz P, Kaschka I, Lang S, Roessler K, Knossalla F, Doerfler A. Neurocrit Care; 2016 Aug; 25(1):40-6. PubMed ID: 26690939 [Abstract] [Full Text] [Related] Page: [Next] [New Search]